콘텐츠로 건너뛰기
Merck
  • Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells.

Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells.

Nature cell biology (2013-11-19)
Yun Xia, Emmanuel Nivet, Ignacio Sancho-Martinez, Thomas Gallegos, Keiichiro Suzuki, Daiji Okamura, Min-Zu Wu, Ilir Dubova, Concepcion Rodriguez Esteban, Nuria Montserrat, Josep M Campistol, Juan Carlos Izpisua Belmonte
초록

Diseases affecting the kidney constitute a major health issue worldwide. Their incidence and poor prognosis affirm the urgent need for the development of new therapeutic strategies. Recently, differentiation of pluripotent cells to somatic lineages has emerged as a promising approach for disease modelling and cell transplantation. Unfortunately, differentiation of pluripotent cells into renal lineages has demonstrated limited success. Here we report on the differentiation of human pluripotent cells into ureteric-bud-committed renal progenitor-like cells. The generated cells demonstrated rapid and specific expression of renal progenitor markers on 4-day exposure to defined media conditions. Further maturation into ureteric bud structures was accomplished on establishment of a three-dimensional culture system in which differentiated human cells assembled and integrated alongside murine cells for the formation of chimeric ureteric buds. Altogether, our results provide a new platform for the study of kidney diseases and lineage commitment, and open new avenues for the future application of regenerative strategies in the clinic.

MATERIALS
제품 번호
브랜드
제품 설명

Supelco
Tretinoin, Pharmaceutical Secondary Standard; Certified Reference Material
Tretinoin, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Retinoic acid, ≥98% (HPLC), powder